SCHEMBL4243231

SCHEMBL4243231

CC[N]c1ccccc1CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
GABRA1 P14867 4/20 0.41
GABRB2 P47870 4/20 0.41
MGLL Q99685 1/20 0.38
CYP2D6 P10635 2/20 0.37
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6560084 0.82 CYP3A4 (0.42) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21102318 0.80 SIGMAR1 (0.47) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL15274890 0.80 SIGMAR1 (0.47) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL49570 0.80 SIGMAR1 (0.47) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL944030 0.78 SIGMAR1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7053823 0.78 SIGMAR1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13170477 0.76 SIGMAR1 (0.44) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16864159 0.76 GABRA1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL722841 0.74 GABRA1 (0.47) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL442008 0.73 TSHR (0.43) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127815-A1 AMINOALYL-IMIDAZOTETRAZINES FOR TREATMENT OF CANCER THE UNIVERSITY OF BRADFORD (GB) 2009-10-22 WO claimed
CN-109289048-B Tumor vascular blocking synergistic phototherapeutic reagent and synthesis method and application thereof 南京工业大学 2021-05-25 CN disclosed
WO-2009127815-A1 AMINOALYL-IMIDAZOTETRAZINES FOR TREATMENT OF CANCER THE UNIVERSITY OF BRADFORD (GB) 2009-10-22 WO disclosed
US-7138539-B2 Colorant compounds containing copolymerizable vinyl groups EASTMAN CHEMICAL COMPANY (US) 2006-11-21 US disclosed
US-7060829-B2 Colorant compounds containing copolymerizable vinyl groups EASTMAN CHEMICAL COMPANY (US) 2006-06-13 US disclosed
US-7030244-B2 Colorant compounds containing copolymerizable vinyl groups EASTMAN CHEMICAL COMPANY (US) 2006-04-18 US disclosed
US-20060052469-A1 Colorant compounds containing copolymerizable vinyl groups CYR MICHAEL J 2006-03-09 US disclosed
US-6727372-B2 PHOTOPOLYMERIZATION; ADDITION POLYMERS EASTMAN CHEMICAL COMPANY 2004-04-27 US disclosed
EP-0581065-B1 Combination of photosensitive elements for use in radiography IMATION CORP (US) 1999-10-20 EP disclosed
EP-0661592-B1 Radiographic assembly for chest examination IMATION CORP (US) 1999-09-22 EP disclosed
US-5136028-A Red; colorfastness CIBA-GEIGY CORPORATION (US) 1992-08-04 US disclosed
US-5070248-A Green phosphor and uv phosphor MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-12-03 US disclosed
US-5024928-A Containing monomethine cyanine dye and thiazole quartnary salt MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-18 US disclosed
EP-0428482-A1 Reactive dyes, process for their preparation and their use CIBA-GEIGY AG (CH) 1991-05-22 EP disclosed
EP-0412730-A2 An improved cassette and radiographic film combination MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-02-13 EP disclosed
EP-0403874-A1 Light-sensitive elements for radiographic use and process for the formation of an x-ray image MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-12-27 EP disclosed
EP-0350883-A2 Combination of photosensitive elements for use in radiography MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-01-17 EP disclosed
EP-0345483-A2 Light-sensitive elements for radiographic use and process for the formation of an X-ray image MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-12-13 EP disclosed
EP-0345444-A1 Light-sensitive non-silver photographic element and process for incorporating hydrophobic compositions into hydrophilic colloid compositions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-12-13 EP disclosed
US-4419352-A ANTIALLERGENS; ANTI SECRETORY AGENTS; MUCUS FISONS LIMITED (GB) 1983-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052469-A1 Colorant compounds containing copolymerizable vinyl groups ALOX5, ALAD, EED SIGMAR1 3442/4885GRIN2D 1127/4885GRIN3B 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.